103 related articles for article (PubMed ID: 33813415)
1. Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.
Boczar D; Bagaria SP; Spaulding AC; Huayllani MT; Avila FR; Guliyeva G; Lu X; Rinker BD; Forte AJ
Anticancer Res; 2021 Apr; 41(4):2067-2070. PubMed ID: 33813415
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities and insurance status: An epidemiological analysis of Ohio melanoma patients.
Kooistra L; Chiang K; Dawes S; Gittleman H; Barnholtz-Sloan J; Bordeaux J
J Am Acad Dermatol; 2018 May; 78(5):998-1000. PubMed ID: 29138060
[No Abstract] [Full Text] [Related]
3. Disparities in the Presentation and Management of Cutaneous Melanoma That Required Admission.
Al-Qurayshi Z; Srivastav S; Wang A; Boh E; Hamner J; Hassan M; Kandil E
Oncology; 2018; 95(2):69-80. PubMed ID: 29913445
[TBL] [Abstract][Full Text] [Related]
4. Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis.
Sitenga JL; Aird G; Ahmed A; Walters R; Silberstein PT
Int J Dermatol; 2018 Oct; 57(10):1149-1156. PubMed ID: 29736922
[TBL] [Abstract][Full Text] [Related]
5. Disparities in the Receipt of Systemic Treatment in Metastatic Melanoma.
Kakish H; Pawar O; Bhatty M; Doh S; Mulligan KM; Rothermel LD; Bordeaux JS; Mangla A; Hoehn RS
Am J Clin Oncol; 2024 May; 47(5):239-245. PubMed ID: 38251734
[TBL] [Abstract][Full Text] [Related]
6. Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.
Hayek SA; Munoz A; Dove JT; Hunsinger M; Arora T; Wild J; Shabahang M; Blansfield J
Am Surg; 2018 May; 84(5):672-679. PubMed ID: 29966567
[TBL] [Abstract][Full Text] [Related]
7. Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.
Amini A; Rusthoven CG; Waxweiler TV; Jones BL; Fisher CM; Karam SD; Raben D
J Am Acad Dermatol; 2016 Feb; 74(2):309-16. PubMed ID: 26670715
[TBL] [Abstract][Full Text] [Related]
8. Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.
Lorimer PD; Benham EC; Walsh K; Han Y; Forster MR; Sarantou T; White RL; Hill JS
J Surg Oncol; 2017 Mar; 115(3):281-286. PubMed ID: 28335082
[TBL] [Abstract][Full Text] [Related]
9. Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.
Kearney M; Thokagevistk K; Boutmy E; Bharmal M
J Med Econ; 2018 Dec; 21(12):1159-1171. PubMed ID: 30149739
[TBL] [Abstract][Full Text] [Related]
10. Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.
Haque W; Verma V; Butler EB; Teh BS
J Immunother; 2019; 42(6):228-235. PubMed ID: 30985445
[TBL] [Abstract][Full Text] [Related]
11. Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
Look Hong NJ; Cheng SY; Baxter NN; Wright FC
J Surg Oncol; 2018 Mar; 117(4):597-617. PubMed ID: 29228470
[TBL] [Abstract][Full Text] [Related]
12. Association of Sociodemographic Factors With Immunotherapy Receipt for Metastatic Melanoma in the US.
Moyers JT; Patel A; Shih W; Nagaraj G
JAMA Netw Open; 2020 Sep; 3(9):e2015656. PubMed ID: 32876684
[TBL] [Abstract][Full Text] [Related]
13. Failure to operate on resectable gastric cancer: implications for policy changes and regionalization.
Frohman HA; Martin JT; Le AT; Dineen SP; Tzeng CD
J Surg Res; 2017 Jun; 214():229-239. PubMed ID: 28624049
[TBL] [Abstract][Full Text] [Related]
14. Suboptimal Compliance With National Comprehensive Cancer Network Melanoma Guidelines: Who Is at Risk?
Blakely AM; Comissiong DS; Vezeridis MP; Miner TJ
Am J Clin Oncol; 2018 Aug; 41(8):754-759. PubMed ID: 28121641
[TBL] [Abstract][Full Text] [Related]
15. Asian American and Pacific Islander patients with melanoma have increased odds of treatment delays: A cross-sectional study.
Fane LS; Wei AH; Tripathi R; Bordeaux JS
J Am Acad Dermatol; 2023 Sep; 89(3):529-536. PubMed ID: 37224968
[TBL] [Abstract][Full Text] [Related]
16. Variation among pathologists' treatment suggestions for melanocytic lesions: A survey of pathologists.
Lee KC; Peacock S; Weinstock MA; Zhao GA; Knezevich SR; Elder DE; Barnhill RL; Piepkorn MW; Reisch LM; Carney PA; Onega T; Lott JP; Elmore JG
J Am Acad Dermatol; 2017 Jan; 76(1):121-128. PubMed ID: 27692732
[TBL] [Abstract][Full Text] [Related]
17. Association of socioeconomics, surgical therapy, and survival of early stage hepatocellular carcinoma.
Peters NA; Javed AA; He J; Wolfgang CL; Weiss MJ
J Surg Res; 2017 Apr; 210():253-260. PubMed ID: 28457336
[TBL] [Abstract][Full Text] [Related]
18. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
[TBL] [Abstract][Full Text] [Related]
19. Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States.
Abudu B; Cook KA; Gershenwald JE; Cohen PR; Geller AC
Cancer; 2020 Feb; 126(4):775-781. PubMed ID: 31714593
[TBL] [Abstract][Full Text] [Related]
20. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society.
Chang AE; Karnell LH; Menck HR
Cancer; 1998 Oct; 83(8):1664-78. PubMed ID: 9781962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
